ATF6 and lung carcinoma: Utilizing TUSC3KO and TUSC3/HRD1 DKO cells, we found that ATF6α pathway, but not IRE1α and PERK pathways was selectively enhanced in TUSC3 deficient cells, possibly mediated the function of TUSC3 deficiency in lung cancer metastasis.